Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study

Title:	Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study
Authors:	Bilgin, Burak^{Aff1, IDs00432020035016_cor1}; Sendur, Mehmet Ali Nahit^Aff2; Yucel, Sebnem^Aff1; Celik, Emir^Aff3; Ozyukseler, Deniz Tataroglu^Aff4; Ayhan, Murat^Aff4; Basoglu, Tugba^Aff5; Ilhan, Aysegul^Aff6; Akdeniz, Nadiye^Aff7; Gulmez, Ahmet^Aff8; Dogan, Izzet^Aff9; Aktas, Burak Yasin^Aff10; Gurbuz, Mustafa^Aff11; Koca, Sinan^Aff12; Paydas, Semra^Aff13; Tatli, Ali Murat^Aff14; Cinkir, Havva Yesil^Aff15; Alan, Ozkan^Aff16; Erol, Cihan^Aff2; Hizal, Mutlu^Aff2; Kut, Engin^Aff17; Menevse, Serkan^Aff17; Sakalar, Teoman^Aff18; Taskaynatan, Halil^Aff18; Deniz, Gulhan Ipek^Aff19; Karaagac, Mustafa^Aff20; Avci, Okan^Aff21; Sen, Erdem^Aff22; Karatas, Fatih^Aff23; Akinci, Muhammed Bulent^Aff2; Dede, Didem Sener^Aff2; Demir, Atakan^Aff24; Demirkazık, Ahmet^Aff11; Oksuzoglu, Berna^Aff6; Kilickap, Sadettin^Aff10; Yumuk, Fulden^Aff5; Yalcin, Bulent^Aff2
Source:	Journal of Cancer Research and Clinical Oncology. 147(7):2145-2152
Database:	Springer Nature Journals